4th Annual
Pulmonary Embolism Symposium:
What is Known, and What We Need to Know

June 22-23, 2018 / Nashville, TN

4th Annual Pulmonary Embolism (PE) Symposium

This annual two day AMA PRA/ANCC-accredited conference entitled, Pulmonary Embolism: What is Known, and What We Need to Know:  A State of the Art and Scientific Update’, is designed for practicing clinicians who regularly care for patients with pulmonary embolism (PE), as well as those who are interested in studying the pathophysiology, epidemiology, diagnosis, medical and interventional management, novel treatment paradigms, and outcomes of PE

Many would say that, when it comes to PE, we have an international crisis, given the prevalence of this disease, its enormous impact, and the relative lack of progress in its management. In fact, in 2008, the Surgeon General issued a “Call to Action” to improve the prevention, diagnosis and treatment of PE. Therefore, the purpose of this symposium is to improve the understanding of the pathophysiology, epidemiology, diagnosis, prevention and treatment of PE by educating our medical colleagues through a series of lectures and interactive discussions with thought leaders in the field.

Specifically, the goals of this Annual Scientific Symposium are:

  • To educate the medical community on the latest advances in the diagnosis, risk stratification and treatment of PE.
  • To explore the science behind PE diagnosis and treatment share knowledge regarding PE management.
  • To provide a forum for presentation of novel approaches to PE management, as they arise.
  • To recognize the potential complications from PE and how to prevent and treat them.
  • To highlight unique patient populations and their specific treatment challenges.
  • To promote and enhance coordinated, multidisciplinary care of PE patients.
  • To explore opportunities for quality improvement in PE management

 

Registration

Please click the link above to register for the meeting. In order to register, you will first have to create an account with the Boston University CME office and then proceed to sign up for the event.

Required Fees

MD/DO Early Bird Registration
($395 after May 1, 2018)
$250.00
Professional from Founding/Institutional Member
or Provisional PERT Consortium Member

(Must be validated by Staff)
$150.00
Nurse/NP/PA $150.00
Fellow/Trainee $99.00
Industry Professionals $500.00

 

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and PERT Consortium.Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.Boston University School of Medicine designates this live activity for a maximum of 11.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This educational activity is being provided by Continuing Nursing Education Provider Unit, Boston University School of Medicine and jointly-provided by PERT Consortium.

Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

 

Program Overview

Day 1: Friday, June 22
6:30-7:50 AM
Registration / Continental Breakfast
7:50–8:00
Welcome and Opening Remarks
8:00–9:00
SESSION I
PE EPIDEMIOLOGY & GLOBAL IMPACT, CLINICAL PRESENTATION & PREDICTIVE MODELING
-
Bending the PE Curve: Raising Awareness and Reducing the Global Impact of the PE Epidemic
Pre-test Probability: How well can we predict the presence of PE… what do the data show?
Increasing sensitivity and specificity in detection of PE: Use of the PERC Rule and other tools?
Look at the patient, not just the studies!
- Key clues on physical exam suggesting the diagnosis of PE
-”Fool me once, but don’t fool me twice”—The many faces of PE (Case-based presentation with Audience polling)
Interactive Panel Discussion - Q & A with the Experts
9:00–10:00
SESSION II
DIAGNOSTIC EVALUATION: ADVANCES IN IMAGING, LAB, AND CLINICAL ASSESSMENT
CT for diagnosis and risk-stratification in PE - What’s the Latest?
More POCUS, Less HOKUS...Role of Point Of Care UltraSound for Diagnosis
Case Challenges ...I thought I had it right!
(Echos, CTA’s, with Unexpected Findings)
Audience Polling
Interactive Panel Discussion - Q & A with the Experts
10:05–10:20
Break / Visit Exhibits
10:20–11:40
SESSION III
DEFINING PE SEVERITY TO TRIAGE CARE... GUIDELINES, MANAGEMENT DECISIONS AND PERTS
European Guidelines - Best evidence-based approach available?
Biomarkers and Clinical Risk Scores: How accurate/effective are they to stratify risk?
Hypoxemia in Acute Pulmonary Embolism—Pathophysiology and Influence on Management
The “IDEAL” Guidelines—What data are still required to create these?
The GREAT PERT Debate I: Value of Team-based Care
Pro: Team-based care increases institutional awareness and enhances care for PE patients
Con: The challenges of team-based care- increased complexity and delay in therapy
Interactive Panel Discussion - Q & A with the Experts
11:40–12:00 PM
Patient Perspective - Interview and Audience Q&A
12:00–1:15
Lunch and Sponsored Satellite Sessions
1:15–2:20
SESSION IV
ANTICOAGULATION UPDATE: CONTROVERSY AND PROGRESS
Case Presentation with audience polling
The GREAT PERT Debate II: Anticoagulation Alone Versus Lysis
Pro: Intermediate High-risk Submassive PE is best treated with anticoagulation alone!
Con: Intermediate High-risk Submassive PE is best treated with systemic or catheter-directed thrombolysis!
2018 Update on Direct Oral Anticoagulants (DOACs) for VTE treatment: Role as primary therapy for PE and transition after lysis...the Anticoagulation Revolution Continues
Bridging from inpatient to outpatient prophylaxis - from Exclaim to Mariner
Interactive Panel Discussion - Q & A with the Experts
2:25–3:25
SESSION V
BREAKOUT SESSIONS
Breakout Session I
“After the PE”: Long Term Surveillance and Post-PE Syndromes (CTED and CTEPH)
Breakout Session II
Quality Assurance In PE Treatment: Benchmarking Outcomes with a QA Program
Breakout Session III
Practical Guide to Anticoagulation: What agents, how long, and in which patients… What you need to know!
Breakout Session IV
What was I thinking?
Complications and missed opportunities in management of PE and VTE cases
3:25–3:45
Break / Visit Exhibits
3:45–4:45
SESSION VI
INTERVENTIONAL BATTLE ROYALE: SPARRING WITH THE EXPERTS ON CHOICE OF ADVANCED CATHETER-BASED THERAPY
Catheter Directed Lysis
“Hot off the Press”: Optylase influence on clinical use of Ultrasound Facilitated Lysis
Small Catheter Aspiration
Large Catheter Aspiration
Thrombectomy with Veno-veno Bypass
Rheolytic Thrombectomy
Clot in Transit: Sword of Damocles
Interactive Panel Discussion - Q & A with the Experts
4:50–5:30
Poster/Abstract Competition with Moderated Presentations
Moderator: Rachel Rosovsky, Belinda Rivera-Lebron, Aaron Weinberg, Alison Witkin
5:30–7:00
Reception with Sponsors
Day 2: Saturday, June 23
7:00-8:00 AM
Sponsored Satellite Sessions
6:30–8:00
Registration / Continental Breakfast
8:00–8:10
Welcome and Opening Remarks
8:10-9:10
SESSION VII
SYMPOSIUM ON MASSIVE PE - SURGERY, CARDIOPULMONARY SUPPORT, AND CRITICAL CARE
Massive PE with and without Cardiovascular Collapse - do we need better definitions?
IV Thrombolysis - Is it treatment of choice for Massive PE?
Surgery for Massive PE - should it happen more?
CDT for Massive PE...why not?
When to call the ECMO team for Cardiopulmonary support and how to use ECMO as a “bridge” to definitive therapy
Right Ventricular Support - Indications and Options
Cardiac Arrest and Unstable PE in the Critical Care Unit - Clinical pearls
“Hot off the Press”- Role of inhaled nitric oxide in PE…the iNOPE trial
Interactive Panel Discussion - Q & A with the Experts
9:10–10:35
SESSION VIII
BEST PRACTICE FOR PE MANAGEMENT: CONTROVERSIES AND CONUNDRUMS
“Transfer PE”- Best practices for stabilization and transfer of patients with large PE in Community-based Setting
The Great PERT Debate III: All high-risk PE’s should be transferred to a PE Center of Excellence with the full range of therapies available
Pro: IVC Filters can be lifesaving and should be used more routinely in PE patients
Con: IVC Filters are not indicated and should almost never be implanted
Indications to leave the filter in, and how to make sure the others come out
What is the Definition of “Good PE Care”? Establishing Metrics and Benchmarks for Excellence
PE Quality Mandate: What is the Role of the PERT QA and Research Registry (PQRR)
Interactive Panel Discussion - Q & A with the Experts
10:35–10:55
Break / Visit Exhibits
10:55–12:10
WORKSHOPS — BLOCK I
“DEEP DIVE” PEER-TO-PEER SESSIONS & HANDS-ON WORKSHOPS
Workshop I
DVT and IVC Filter — Hands-on device workshop
Workshop II
Challenging Patient Subsets - Part 1:
PE in pregnancy, cancer patients, hemophila patients, and more
Workshop III
Latest In CTEPH Management - Surgery and BPA
Workshop IV
Invasive Management & Hemodynamic Support in Massive Pe
—Hands on device workshop
12:10–1:30
Lunch and Sponsored Satellite Sessions
1:30–1:50
The Most Complicated PE Case You Can Imagine
Case Presentation & Discussion with Experts
1:50–3:15
SESSION IX
THE PE RESEARCH MANDATE: FILLING THE EVIDENCE GAP
Most important current and future research in PE
The INVENT Clinical Trials Network: Will this provide us the answers we seek?
FDA’s role and Perspective on filling the evidence gap
Interactive Panel Discussion - Q & A with the Experts
-
Most Interesting PE Papers Of The Year - Panel Discussion
3:15–3:20
Course Directors Wrap-up
3:20–3:30
Break
3:30–4:45
WORKSHOPS — BLOCK II
“DEEP DIVE” PEER-TO-PEER SESSIONS & HANDS-ON WORKSHOPS
Workshop V
Social Media, PERT Apps, and more: Tools to inform patients and help me manage PE
Workshop VI
Outpatient Management Of Low Risk PE:
Algorithms for successful treatment and prevention of recurrence
Workshop VII
Advanced Thrombectomy Hands-On Device Workshop:
How to use these devices most effectively and safely
Workshop IV
Challenging Patient Subsets- Part 2:
Case-based approach for patients at high risk for bleeding - Neuro, Post-op, Trauma, and Thrombocytopenic Patients
4:45
Adjourn

Faculty

W. Brent Keeling, MD
COURSE DIRECTOR
Geno J. Merli, MD
COURSE DIRECTOR
Kenneth Rosenfield, MD, MHCDS
COURSE DIRECTOR
Victor Tapson, MD, FCCP, FRCP
COURSE DIRECTOR

Invited Faculty

ASSOCIATE COURSE DIRECTORS

William R. Auger, MD
UC San Diego School of Medicine
San Diego, California

Geoff Barnes, MD, MSc
University of Michigan Health
System
Ann Arbor, MI

Jerry Bartholomew, MD
Cleveland Clinic
Cleveland, Ohio

James F. Benenati, MD
Miami Baptist Hospital
Miami, FL

Richard N. Channick, MD
Mass General Hospital for Children
Boston, MA

George Davis, PharmD
University of Kentucky College
of Pharmacy
Lexington, KY

Oren Friedman, MD
Cedars-Sinai Medical Center
Los Angeles, CA

Jay Giri, MD
Hospital of the University
of Pennsylvania
Philadelphia, PA

Sam Goldhaber, MD
Brigham and Women’s Hospital
Boston, MA

Gustavo A. Heresi, MD
Cleveland Clinic
Cleveland, OH

James Horowitz, MD
NYU Langone School of Medicine
New York, NY

Michael Jaff, DO
Newton Wellesley Hospital
Newton, MA

Christopher Kabrhel, MD
Massachusetts General Hospital
Boston, MA

Andrew J. P. Klein, MD
Piedmont Heart Institute
Atlanta, GA

Robert Lookstein, MD
The Mount Sinai Hospital
New York, NY

Robert Maholic, DO
University of Pittsburgh
Medical Center
Pittsburgh, PA

Jana Montgomery, MD
Lahey Hospital & Medical Center
Burlington, MA

Soophia Naydenov, MD, FCCP
SSM Health Saint Louis
University Hospital
St. Louis, MO

Charles B. Ross, MD
Piedmont Heart Institute
Atlanta, GA

Akhilesh K. Sista, MD
NYU Langone School of Medicine
New York, NY

David A. Slosky, MD
Vanderbilt Heart
Nashville, TN

Roy E. Smith, MD
University of Pittsburgh Medical
Center
Pittsburgh, PA

Seth Sokol, MD
Jacobi Medical Center
Bronx, NY

Thomas M. Todoran, MD, MSc
Medical University of South
Carolina
Charleston, SC

 

 

SCIENTIFIC ABSTRACT & ASSOCIATE COURSE DIRECTORS

Belinda N. Rivera-Lebron, MD
University of Pittsburgh Medical
Center
Pittsburgh, PA
Rachel Rosovsky, MD
Massachusetts General Hospital
Boston, MA
Aaron Weinberg, MD
Cedars Sinai Medical Center
Los Angeles, CA
Alison S. Witkin, MD
Massachusetts General Hospital
Boston, MA

 

 

INVITED FACULTY

Riyaz Bashir, MD
Temple University
Philadelphia, PA

Joshua Beckman, MD
Vanderbilt University
Medical Center
Nashville, TN

Rohit Bhatheja, MD
Florida Hospital
Orlando, FLA

Brett Carrol, MD
Brigham and Women’s Hospital
Boston, MA

Joanna Chikwe, MD
Mount Sinai
New York, NY

Mark Courtney, MD
Northwestern University
— Feinberg School of Medicine
Chicago, IL

Adam C. Cuker, MD
University of Pittsburgh
Medical Center
Pittsburgh, PA

James Douketis, MD
McMaster University
Hamilton, ON, Canada

Alain Drooz, MD
Inova
Fairfax, VA

David Dudzinski, MD
Massachusetts General Hospital
Boston, MA

Robert T. Eberhardt, MD
Boston Medical Center
Boston, MA

Mahir D. Elder, MD
Detroit Medical Center
Detroit, MI

John Fanikos, MBA, RPh
Brigham and Women’s Hospital
Boston, MA

Caio Fernandes, MD
University of Sao Paulo
Sao Paulo, Brazil

C. Michael Gibson, MS, MD
Baim Institute for Clinical Research
Boston, MA

John Gurley, MD
University of Kentucky College
of Medicine
Lexington, KY

Ethan Halpern, MD
Jefferson University Hospital
Philadelphia, PA

John A. Heit, MD
Mayo Clinic
Rochester, MN

Andrew Hirsch, MD
Jewish General Hospital
Montréal, Qué., Canada

Menno Huisman, MD, PhD
Leiden University Medical Center
Leiden, Netherlands

Wissam Jaber, MD
Emory School Of Medicine
Atlanta, GA

David Jiménez, MD
Ramon y Cajal Hospital IRYCIS
Alcala de Henares University
Madrid, Spain

David Joyce, MD
Froedtert Hospital
Milwaukee, WI

Scott Kaatz, DO
Henry Ford Hospital
Detroit, MI

John A. Kaufman, MD
Oregon Health
& Science University
Portland, OR

Clive Kearon, MB, MRCPI
McMaster University
Hamilton, ON, Canada

Nick H. Kim, MD
UC San Diego
La Jolla, CA

Jeffrey A. Kline, MD
Indiana University Medical Center
Indianapolis, IN

Raghu Kolluri, MD
OhioHealth Heart & Vascular
Columbus, OH

Irene Lang, MD
Medical University of Vienna
Wien, Austria

Matthew D. Langston, MD
Albert Einstein College
of Medicine
Bronx, NY

Omar Lattouf, MD
Emory University School
of Medicine
Atlanta, GA

Ehtisham Mahmud, MD
University of California
San Diego
San Diego, CA

Mark Marinescu, MD
Ohio State University
Columbus, OH

Sagger Mawri, MD
Henry Ford Hospital
Detroit, MI

Michael McDaniel, MD
Grady Memorial Hospital
Atlanta, GA

Guy Meyer, MD
Paris Descartes University
Paris, France

Chad E. Miller, MD
Piedmont Healthcare
Atlanta, GA

Manuel Monreal, MD
Hospital Universitari
Germans Trias i Pujo
Barcelona, Spain

Jose Pablo Morales, MD
U.S. Food and
Drug Administration
Washington, DC

John Moriarty, MD
UCLA Medical Center
Los Angeles, CA

Jeffrey W. Olin, DO
The Mount Sinai Hospital
New York, NY

Sahil A. Parikh, MD
NewYork-Presbyterian Hospital
New York, NY

Blair Parry, MD
Massachusetts General Hospital
Boston, MA

Gregory Piazza, MD
Brigham and Women’s Hospital
Boston, MA

Steven Pugliese, MD
Perelman Center for
Advanced Medicine
Philadelphia, PA

Parth Rali, MD
Temple University Hospital
Philadelphia, PA

Mahmood Razavi, MD
St. Joseph Hospital
Orange, CA

Belinda N. Rivera-Lebron, MD
University of Pittsburgh
Medical Center
Pittsburgh, PA

Rachel Rosovsky, MD
Massachusetts General Hospital
Boston, MA

Robert M. Schainfeld, DO
Massachusetts General Hospital
Boston, MA

Ashish Shah, MD
Andover Medical Center
Andover, MA

Susan Smyth, MD
University of Kentucky
College of Medicine
Lexington, KY

Keith Sterling, MD
Inova Alexandria Hospital
Alexandria, VA

Michael Streif, MD
The Johns Hopkins Hospital
Baltimore, MD

Aaron Weinberg, MD
Cedars Sinai Medical Center
Los Angeles, CA

Ido Weinberg, MD
Massachusetts General Hospital
Boston, MA

Jeff Weitz, MD
McMaster University
Hamilton, ON, Canada

Philip Wells, MD, MSc
University of Ottawa
Ottawa, ON, Canada

Frances Mae West, MD
Thomas Jefferson University
Philadelphia, PA

Alison S. Witkin, MD
Massachusetts General Hospital
Boston, MA

Todd Wood, MD
The Heart Group of
Lancaster General Health
Lancaster, PA

Hotel Booking & Visiting Nashville

Sheraton Grand Nashville Downtown
623 Union St
Nashville, TN 37219

To secure accommodations and receive the negotiated special guest rate at the official conference hotel, please reserve by June 4, 2018. To make your reservations, you can book online using the following hotel website link:
https://www.starwoodmeeting.com/Book/PERTConsortium

Or, if you prefer, you can also contact Sheraton Grand Nashville Downtown reservations at 1-888-627-8565 or the hotel directly at 615-259-2000.

 


 

Nashville Skyline NightNashville is the capital of the U.S. state of Tennessee and home to Vanderbilt University. Legendary country music venues include the Grand Ole Opry House, home of the famous “Grand Ole Opry” stage and radio show. The Country Music Hall of Fame and Museum and historic Ryman Auditorium are Downtown, as is the District, featuring honky-tonks with live music and the Johnny Cash Museum, celebrating the singer’s life.

Visit www.visitmusiccity.com/ for more information on things to do and see while in Nashville